Crohn's Disease and Colitis Trial, Recruiting NCT07033208 Sponsor: Massachusetts General Hospital Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT07033208
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 18 and 75 years old
  • People who are generally healthy with no known illnesses
  • People who are able to follow fasting requirements before the procedure
  • People who are able to follow bowel preparation instructions (such as taking a bowel-clearing preparation beforehand)
  • People who are able to give their informed consent to take part

Who may not be able to join:

  • People who are older than 75 years of age
  • People who have trouble swallowing or any swallowing disorder
  • People who have conditions that could increase the risk of a small camera capsule becoming stuck inside the body, such as narrowings in the gut, intestinal tumours, bowel blockages, incomplete colonoscopies, or abnormal connections between organs (confirm with trial site)
  • People who have been diagnosed with a condition where the stomach or intestines do not move food through properly (such as gastroparesis or bowel dysmotility)
  • People with a history of inflammatory bowel disease, Crohn's disease affecting the intestines, long-term constipation, or bleeding from the back passage
  • People with known kidney disease or abnormal kidney function test results in the past 6 months
  • People who regularly use anti-inflammatory pain medications such as ibuprofen or naproxen (NSAIDs)
  • People who have a known reason they cannot take the medication metoclopramide
  • People who have a known reason they cannot take polyethylene glycol (a bowel preparation solution)
  • People currently suspected of having or diagnosed with blood in the stool, black tarry stools, or iron deficiency with or without anaemia
  • People who have had surgery on their intestines in the past
  • People with a history of heart failure
  • People who have been diagnosed with Type 1 or Type 2 Diabetes
  • People who have a cardiac pacemaker or any other implanted electronic medical device
  • People who are expected to have an MRI scan within 7 days of swallowing the capsule
  • People who have taken part in another clinical research study involving a drug or medical device within the past 30 days, where that study may affect their safety or ability to participate
  • People who have delayed stomach emptying
  • People who are pregnant, may be pregnant, or are currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Guillermo Tearney, MD, PhD, Massachusetts General Hospital

Phone: 6177244515

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
3 June 2025
Est. completion
30 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Measurement of Gastrointestinal Temperature Mean Variance in adult study participants as measured by the wireless thermal capsule

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov